MITAKY
MITAKY is a Japanese technology company.
Q1. Is ADSC therapy safe?
“Yes, ADSC therapy is safe as it uses autologous cells (your own), minimising the risk of immune rejection and adverse reactions. All procedures are conducted under stringent medical guidelines in CPC-certified facilities by Japan’s Ministry of Health, Labour & Welfare, to ensure the highest standards of safety and quality.”
View in the company profileQ2. How long does the treatment take?
“The entire process, from initial consultation to reinfusion, typically takes 4-6 weeks. The reinfusion itself is a one-day outpatient procedure with several hours only.”
View in the company profileQ3. When will I see results?
“Results vary depending on the condition treated, but most patients report noticeable improvements within 1-3 months post-infusion.”
View in the company profileQ4. Is the therapy painful?
“The procedure is minimally invasive, with most patients experiencing only mild discomfort during the extraction and reinfusion phases.”
View in the company profileQ5. How long do the effects last?
“The longevity of the treatment’s effects depends on the individual and the condition treated. However, many patients experience long-term benefits, with some reporting improvements lasting several years.”
View in the company profileQ7. Can I undergo ADSC therapy if I have other medical conditions?
“ADSC therapy is generally safe for patients with various medical conditions, but it is crucial to have a thorough consultation with our Japanese physician & doctors. Conditions such as uncontrolled diabetes, severe infections, or active cancers may require special consideration before proceeding with therapy.”
View in the company profile